Company Filing History:
Years Active: 2024-2025
Title: Innovations by Else Marit Inderberg
Introduction
Else Marit Inderberg is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of medicine, particularly in cancer treatment. With a total of 2 patents, her work focuses on innovative therapeutic approaches.
Latest Patents
Inderberg's latest patents include groundbreaking research on chimeric antigen receptors (CARs) that target osteosarcoma. These CARs, when expressed on immune cells, can effectively direct these cells to attack osteosarcoma cells. In murine models, T cells expressing these CARs demonstrated a significant delay in tumor growth. Additionally, her work on specific binding molecules for hTERT provides a nucleic acid molecule capable of binding an hTERT peptide, which has potential applications in cancer treatment.
Career Highlights
Inderberg is affiliated with Oslo Universitetssykehus HF, where she continues her research and development in the field of oncology. Her innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
She collaborates with notable colleagues such as Sébastian Wälchli and Øyvind S Bruland, contributing to a dynamic research environment focused on advancing cancer therapies.
Conclusion
Else Marit Inderberg's contributions to medical innovation, particularly in cancer treatment, highlight her role as a leading inventor in her field. Her patents reflect a commitment to improving therapeutic outcomes for patients.